Some visit links earn us a commission.
Quick verdict
Hone Health is the better pick for most patients on overall scoring. Hone Health targets men's hormone optimization (testosterone, semaglutide, peptides) with an at-home blood-draw model. GLP-1 added in 2024 as part of the metabolic-optimization product line. Strong for the testosterone+GLP-1 stack; less obesity-medicine depth than Form Health.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Embla | Hone Health | |
|---|---|---|
| Starts from | $249/mo (+ med separate) | $185/mo (+ med separate) |
| Monthly cost gap | Hone Health is $64/mo cheaper than Embla | |
| Lock-in | 12-mo lock-in | Month-to-month |
| Time to prescription | 7 days | 7 days |
| Consultation type | Live | Video |
| Affiliate network | Impact | Direct |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Embla | Hone Health | |
|---|---|---|
| Pricing transparency | 4/10 | 6/10 |
| Cancellation terms | 7/10 | 7/10 |
| Onboarding experience | 6/10 | 7/10 |
| Medication options | 7/10 | 7/10 |
| Member reviews | 9.2/10 | 9.6/10 |
When to choose Embla
Best for structured behavior support
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
Embla wins on tied dimensions on the dimensional scoring. The caveat: Buyers who only want the script and find coaching content patronizing.
When to choose Hone Health
Best for men's hormone plus GLP-1 stack
Men interested in combined hormone-optimization and weight loss. Patients who want at-home blood draws and broader metabolic protocols beyond standard obesity care.
Hone Health wins on pricing transparency, onboarding experience, member reviews and runs $64/mo cheaper than Embla at the entry tier ($185 vs $249). Over a year that's $768 you keep. The caveat: Patients seeking obesity-medicine specialization, women's-specific needs or the cheapest cash-pay path. Note also: Hone markets compounded peptides beyond GLP-1; the broader peptide-marketing landscape has higher 2025-2026 regulatory exposure than GLP-1 alone
If cost is your main filter
Hone Health is the cheaper monthly: $185 all-in vs $249 for Embla. That's $64 a month or $768a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $192 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Embla (12-mo lock-in) and Hone Health (month-to-month) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Hone Health's easier cancellation is the safer trial.
FAQ
Is Embla cheaper than Hone Health?
Can I switch from Embla to Hone Health mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
